HELM Portugal announces an exclusive distribution agreement with CSPC Weisheng Pharmaceutical (Shijiazhuang) Co. Ltd.
According to HELMs Supply Chain experts, the impact of the Novel Coronavirus will certainly be felt in the first quarter of 2020. While there is currently no evident indication on the severity, spread and duration of the outbreak, there are clear indications that the delivery, export and import of products will be affected in the short-term. The Chinese government is asking companies to delay resuming work and transportation has been shut down in some cities and provinces. We recommend our customers to plan their demands according to the volatile situation and increase safety stocks wherever possible.
Pharma is moving fast: Stay on track and prepare your moves. Get the best directions from some of the most experienced professionals on the API market. The HELM Pharma team will share their experiences and insights on the next HELM PHARMA Webinar.
Impact of the Novel Corona virus in the supply chain
The global third-party chemical distribution market is poised to grow by USD 106.81 billion during 2020-2024, progressing at a CAGR of almost 7% during the forecast period. Request free sample pages
HELM Group earnings rise